Patient experiences in medullary thyroid cancer study
Part of Cancer clinical trials.
This trial follows people with medullary thyroid cancer to better understand their experiences. You may join if you have this diagnosis, are 18 or older, and are not taking another experimental drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with medullary thyroid cancer
- You are 18 years old or older
- You are able to give your permission to join the study
- You do not have a serious medical or mental health condition that would make it hard to participate
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You are not currently taking any other investigational (experimental) drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children and adults with medullary thyroid cancer (MTC) and/or MEN2 to better understand how the condition progresses over time. It may help doctors plan care in the future by collecting long-term health and lab information, not by giving a new treatment.
This trial uses a special PET scan to help guide surgery for medullary thyroid cancer (MTC). The goal is to see if this scan can make surgery more precise.
This study follows people with medullary thyroid cancer to better understand how the disease changes over time, including in advanced stages. You may help improve future treatment planning and care for people with medullary thyroid cancer.
This trial asks adults with a neuroendocrine tumor to share their study experiences through surveys or interviews. It may help researchers understand what supports or challenges people face during care and research.
This study is a registry that collects information about adults with certain types of thyroid cancer. It may help researchers learn more about these cancers and how people are doing over time.
This trial tests whether removing half the thyroid with nearby lymph nodes is effective for medullary thyroid cancer. Medullary thyroid cancer is a rare type that starts in cells producing calcitonin, a hormone that controls calcium levels.
Hear when a new Medullary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.